These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Advanced glycation end products and receptors in Fuchs' dystrophy corneas undergoing Descemet's stripping with endothelial keratoplasty. Wang Z; Handa JT; Green WR; Stark WJ; Weinberg RS; Jun AS Ophthalmology; 2007 Aug; 114(8):1453-60. PubMed ID: 17320180 [TBL] [Abstract][Full Text] [Related]
11. Ultraviolet A light induces DNA damage and estrogen-DNA adducts in Fuchs endothelial corneal dystrophy causing females to be more affected. Liu C; Miyajima T; Melangath G; Miyai T; Vasanth S; Deshpande N; Kumar V; Ong Tone S; Gupta R; Zhu S; Vojnovic D; Chen Y; Rogan EG; Mondal B; Zahid M; Jurkunas UV Proc Natl Acad Sci U S A; 2020 Jan; 117(1):573-583. PubMed ID: 31852820 [TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases and their inhibitors in Fuchs endothelial corneal dystrophy. Xu I; Thériault M; Brunette I; Rochette PJ; Proulx S Exp Eye Res; 2021 Apr; 205():108500. PubMed ID: 33617849 [TBL] [Abstract][Full Text] [Related]
13. Expression and Impact of Fibronectin, Tenascin-C, Osteopontin, and Type XIV Collagen in Fuchs Endothelial Corneal Dystrophy. Tchatchouang A; Brunette I; Rochette PJ; Proulx S Invest Ophthalmol Vis Sci; 2024 Apr; 65(4):38. PubMed ID: 38656280 [TBL] [Abstract][Full Text] [Related]